4.2.3 Wellness Hurts
4.3 Diagnostic Technology Development1
4.3.2 NAT vs. Lateral Flow
4.3.3 The Unusual Role of GPS
4.3.4 Self and Send Competition
4.4.5 The Relationship to DTC Genetic
4.4.6 The Relationship to TeleHealth
4.4.7 Sample Collection - Who Knew?
5. OTC/DTC Infectious Disease Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
Lucira Health Files for $115M IPO
Spectrum Solutions Gets CE Mark for Saliva Collection Devices
Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test
LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit
3.2.1 What s Wrong with Microbiology
3.2.2 The Features Battleground of Infectious Disease Diagnostics
3.2.3 Multiplex vs. POC/Rapid
3.2.4 The Miracle of Genetics
3.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation
3.2.6 Gene Sequence Diagnostics WITHOUT the Sequencing
3.2.7 Markers of Resistance
3.4. Antibiotic Resistance Recent Developments
Importance of These Developments
New method to test for infection resistance
Qiagen launches AMR database
Qiagen, Ares Genetics Ink Licensing Pact for AMR Bioinformatics
OpGen to File First 510(k) for AMR Gene Panel
Curetis Subsidiary Ares Genetics Teams Up with Sandoz in Fight Against AMR
GeneCapture to determine antibiotic sensitivity in an automated rapid portable device
Quick identification of multidrug-resistant pathogens
Share this article
Share this article
ResearchAndMarkets.com s offering.
Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID-19 infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies.